Environmental factors shaping the gut microbiome in a Dutch population.


Journal

Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462

Informations de publication

Date de publication:
04 2022
Historique:
received: 23 10 2020
accepted: 18 02 2022
pubmed: 15 4 2022
medline: 30 4 2022
entrez: 14 4 2022
Statut: ppublish

Résumé

The gut microbiome is associated with diverse diseases

Identifiants

pubmed: 35418674
doi: 10.1038/s41586-022-04567-7
pii: 10.1038/s41586-022-04567-7
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

732-739

Subventions

Organisme : European Research Council
Pays : International

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer Nature Limited.

Références

Lynch, S. V. & Pedersen, O. The human intestinal microbiome in health and disease. N. Engl. J. Med. 375, 2369–2379 (2016).
pubmed: 27974040 doi: 10.1056/NEJMra1600266
Liang, D., Leung, R. K., Guan, W. & Au, W. W. Involvement of gut microbiome in human health and disease: brief overview, knowledge gaps and research opportunities. Gut Pathog. 10, 3 (2018).
pubmed: 29416567 pmcid: 5785832 doi: 10.1186/s13099-018-0230-4
Zmora, N., Soffer, E. & Elinav, E. Transforming medicine with the microbiome. Sci. Transl. Med. 11, eaaw1815 (2019).
pubmed: 30700573 doi: 10.1126/scitranslmed.aaw1815
Garber, K. First microbiome-based drug clears phase III, in clinical trial turnaround. Nat. Rev. Drug Discov. 19, 655–656 (2020).
pubmed: 32917977 doi: 10.1038/d41573-020-00163-4
Zhernakova, A. et al. Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity. Science 352, 565–569 (2016).
pubmed: 27126040 pmcid: 5240844 doi: 10.1126/science.aad3369
Gaulke, C. A. & Sharpton, T. J. The influence of ethnicity and geography on human gut microbiome composition. Nat. Med. 24, 1495–1496 (2018).
pubmed: 30275567 doi: 10.1038/s41591-018-0210-8
Vatanen, T. et al. Genomic variation and strain-specific functional adaptation in the human gut microbiome during early life. Nat. Microbiol. 4, 470–479 (2019).
pubmed: 30559407 doi: 10.1038/s41564-018-0321-5
Berry, D. & Widder, S. Deciphering microbial interactions and detecting keystone species with co-occurrence networks. Front. Microbiol. 5, 219 (2014).
pubmed: 24904535 pmcid: 4033041 doi: 10.3389/fmicb.2014.00219
Miquel, S. et al. Faecalibacterium prausnitzii and human intestinal health. Curr. Opin. Microbiol. 16, 255–261 (2013).
pubmed: 23831042 doi: 10.1016/j.mib.2013.06.003
Huang, R. et al. Metagenome-wide association study of the alterations in the intestinal microbiome composition of ankylosing spondylitis patients and the effect of traditional and herbal treatment. J. Med. Microbiol. 69, 797–805 (2020).
pubmed: 31778109 doi: 10.1099/jmm.0.001107
Kandeel, W. A. et al. Impact of Clostridium bacteria in children with autism spectrum disorder and their anthropometric measurements. J. Mol. Neurosci. 70, 897–907 (2020).
pubmed: 32130666 doi: 10.1007/s12031-020-01482-2
Tap, J. et al. Identification of an intestinal microbiota signature associated with severity of irritable bowel syndrome. Gastroenterology 152, 111–123.e8 (2017).
pubmed: 27725146 doi: 10.1053/j.gastro.2016.09.049
Costea, P. I. et al. Enterotypes in the landscape of gut microbial community composition. Nat. Microbiol. 3, 8–16 (2018).
pubmed: 29255284 doi: 10.1038/s41564-017-0072-8
Goodrich, J. K. et al. Genetic determinants of the gut microbiome in UK twins. Cell Host Microbe 19, 731–743 (2016).
pubmed: 27173935 pmcid: 4915943 doi: 10.1016/j.chom.2016.04.017
GEM Project Research Consortium. Association of host genome with intestinal microbial composition in a large healthy cohort. Nat. Genet. 48, 1413–1417 (2016).
doi: 10.1038/ng.3693
Wang, K. et al. Gut microbiota as prognosis markers for patients with HBV-related acute-on-chronic liver failure. Gut Microbes 13, 1–15 (2021).
pubmed: 34132169 doi: 10.1080/19490976.2021.1900996
Wang, P. et al. Cigarette smoking status alters dysbiotic gut microbes in hypertensive patients. J. Clin. Hypertens. 23, 1431–1446 (2021).
doi: 10.1111/jch.14298
Gupta, V. K. et al. A predictive index for health status using species-level gut microbiome profiling. Nat. Commun. 11, 1–16 (2020).
doi: 10.1038/s41467-020-18476-8
Bowyer, R. et al. Socioeconomic status and the gut microbiome: a TwinsUK cohort study. Microorganisms 7, 17 (2019).
pmcid: 6351927 doi: 10.3390/microorganisms7010017
Yatsunenko, T. et al. Human gut microbiome viewed across age and geography. Nature 486, 222–227 (2012).
pubmed: 22699611 pmcid: 3376388 doi: 10.1038/nature11053
Vandeputte, D. et al. Stool consistency is strongly associated with gut microbiota richness and composition, enterotypes and bacterial growth rates. Gut 65, 57–62 (2016).
pubmed: 26069274 doi: 10.1136/gutjnl-2015-309618
Davenport, E. R. et al. Seasonal variation in human gut microbiome composition. PLoS ONE 9, e90731 (2014).
pubmed: 24618913 pmcid: 3949691 doi: 10.1371/journal.pone.0090731
The Microbiome Quality Control Project Consortium. Assessment of variation in microbial community amplicon sequencing by the Microbiome Quality Control (MBQC) project consortium. Nat. Biotechnol. 35, 1077–1086 (2017).
pmcid: 5839636 doi: 10.1038/nbt.3981
Toorn, J. E. et al. Seasonal variation of diet quality in a large middle-aged and elderly Dutch population-based cohort. Eur. J. Nutr. 59, 493 (2020).
pubmed: 30734846 doi: 10.1007/s00394-019-01918-5
Tucker, P. & Gilliland, J. The effect of season and weather on physical activity: a systematic review. Public Health 121, 909–922 (2007).
pubmed: 17920646 doi: 10.1016/j.puhe.2007.04.009
Rothschild, D. et al. Environment dominates over host genetics in shaping human gut microbiota. Nature 555, 210–215 (2018).
pubmed: 29489753 doi: 10.1038/nature25973
Song, S. J. et al. Cohabiting family members share microbiota with one another and with their dogs. eLife 2, e00458 (2013).
pubmed: 23599893 pmcid: 3628085 doi: 10.7554/eLife.00458
Xie, H. et al. Shotgun metagenomics of 250 adult twins reveals genetic and environmental impacts on the gut microbiome. Cell Syst. 3, 572–584.e3 (2016).
pubmed: 27818083 pmcid: 6309625 doi: 10.1016/j.cels.2016.10.004
Oh, M. & Zhang, L. DeepMicro: deep representation learning for disease prediction based on microbiome data. Sci. Rep. 10, 6026 (2020).
pubmed: 32265477 pmcid: 7138789 doi: 10.1038/s41598-020-63159-5
Zimmermann, M., Zimmermann-Kogadeeva, M., Wegmann, R. & Goodman, A. L. Mapping human microbiome drug metabolism by gut bacteria and their genes. Nature 570, 462–467 (2019).
pubmed: 31158845 pmcid: 6597290 doi: 10.1038/s41586-019-1291-3
Imhann, F. et al. Proton pump inhibitors affect the gut microbiome. Gut 65, 740–748 (2016).
pubmed: 26657899 doi: 10.1136/gutjnl-2015-310376
Wu, H. et al. Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug. Nat. Med. 23, 850–858 (2017).
pubmed: 28530702 doi: 10.1038/nm.4345
Bach, J. F. The hygiene hypothesis in autoimmunity: the role of pathogens and commensals. Nat. Rev. Immunol. 18, 105–120 (2018).
pubmed: 29034905 doi: 10.1038/nri.2017.111
Marynowski, M. Role of environmental pollution in irritable bowel syndrome. World J. Gastroenterol. 21, 11371 (2015).
pubmed: 26523104 pmcid: 4616213 doi: 10.3748/wjg.v21.i40.11371
Dujardin, C. E. et al. Impact of air quality on the gastrointestinal microbiome: a review. Environ. Res. 186, 109485 (2020).
pubmed: 32289569 doi: 10.1016/j.envres.2020.109485
Fouladi, F. et al. Air pollution exposure is associated with the gut microbiome as revealed by shotgun metagenomic sequencing. Environ. Int. 138, 105604 (2020).
pubmed: 32135388 pmcid: 7181344 doi: 10.1016/j.envint.2020.105604
Manor, O. et al. Health and disease markers correlate with gut microbiome composition across thousands of people. Nat. Commun. 11, 5206 (2020).
pubmed: 33060586 pmcid: 7562722 doi: 10.1038/s41467-020-18871-1
Sogin, M. L., Morrison, H., McLellan, S., Welch, D. & Huse, S. The rare biosphere: sorting out fact from fiction. Genome Biol. 11, I19 (2010).
pmcid: 3026211 doi: 10.1186/gb-2010-11-s1-i19
Sun, Z. et al. Challenges in benchmarking metagenomic profilers. Nat. Methods 18, 618–626 (2021).
pubmed: 33986544 pmcid: 8184642 doi: 10.1038/s41592-021-01141-3
Scholtens, S. et al. Cohort Profile: LifeLines, a three-generation cohort study and biobank. Int. J. Epidemiol. 44, 1172–1180 (2015).
pubmed: 25502107 doi: 10.1093/ije/dyu229
Tigchelaar, E. F. et al. Cohort profile: LifeLines DEEP, a prospective, general population cohort study in the northern Netherlands: study design and baseline characteristics. BMJ Open 5, e006772 (2015).
pubmed: 26319774 pmcid: 4554905 doi: 10.1136/bmjopen-2014-006772
Siebelink, E., Geelen, A. & de Vries, J. H. M. Self-reported energy intake by FFQ compared with actual energy intake to maintain body weight in 516 adults. Br. J. Nutr. 106, 274–281 (2011).
pubmed: 21338536 doi: 10.1017/S0007114511000067
Brouwer-Brolsma, E. M. et al. A National Dietary Assessment Reference Database (NDARD) for the Dutch population: rationale behind the design. Nutrients 9, 1136 (2017).
pmcid: 5691752 doi: 10.3390/nu9101136
Willett, W. C. et al. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am. J. Epidemiol. 122, 51–65 (1985).
pubmed: 4014201 doi: 10.1093/oxfordjournals.aje.a114086
Vinke, P. C. et al. Development of the food-based Lifelines Diet Score (LLDS) and its application in 129,369 Lifelines participants. Eur. J. Clin. Nutr. 72, 1111–1119 (2018).
pubmed: 29895847 doi: 10.1038/s41430-018-0205-z
Møller, G. et al. A protein diet score, including plant and animal protein, investigating the association with HbA1c and eGFR—the PREVIEW project. Nutrients 9, 763 (2017).
pmcid: 5537877 doi: 10.3390/nu9070763
Leeming, E. R., Johnson, A. J., Spector, T. D. & Le Roy, C. I. Effect of diet on the gut microbiota: rethinking intervention duration. Nutrients 11, 2862 (2019).
pmcid: 6950569 doi: 10.3390/nu11122862
Eeftens, M. et al. Development of land use regression models for PM
pubmed: 22963366 doi: 10.1021/es301948k
Beelen, R. et al. Development of NO
doi: 10.1016/j.atmosenv.2013.02.037
Eeftens, M. et al. Stability of measured and modelled spatial contrasts in NO
pubmed: 21285243 doi: 10.1136/oem.2010.061135
Ford, A. C. et al. Validation of the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care. Gastroenterology 145, 1262–1270.e1 (2013).
pubmed: 23994201 doi: 10.1053/j.gastro.2013.08.048
Angulo, P. et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology 45, 846–854 (2007).
pubmed: 17393509 doi: 10.1002/hep.21496
Bedogni, G. et al. The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 6, 33 (2006).
pubmed: 17081293 pmcid: 1636651 doi: 10.1186/1471-230X-6-33
Imhann, F. et al. The 1000IBD project: multi-omics data of 1000 inflammatory bowel disease patients; data release 1. BMC Gastroenterol. 19, 5 (2019).
pubmed: 30621600 pmcid: 6325838 doi: 10.1186/s12876-018-0917-5
McIver, L. J. et al. bioBakery: a meta’omic analysis environment. Bioinformatics 34, 1235–1237 (2018).
pubmed: 29194469 doi: 10.1093/bioinformatics/btx754
Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357–359 (2012).
pubmed: 22388286 pmcid: 3322381 doi: 10.1038/nmeth.1923
Truong, D. T. et al. MetaPhlAn2 for enhanced metagenomic taxonomic profiling. Nat. Methods 12, 902–903 (2015).
pubmed: 26418763 doi: 10.1038/nmeth.3589
Franzosa, E. A. et al. Species-level functional profiling of metagenomes and metatranscriptomes. Nat. Methods 15, 962–968 (2018).
pubmed: 30377376 pmcid: 6235447 doi: 10.1038/s41592-018-0176-y
Buchfink, B., Xie, C. & Huson, D. H. Fast and sensitive protein alignment using DIAMOND. Nat. Methods 12, 59–60 (2015).
pubmed: 25402007 doi: 10.1038/nmeth.3176
The UniProt Consortium. UniProt: the universal protein knowledgebase. Nucleic Acids Res. 45, D158–D169 (2017).
doi: 10.1093/nar/gkw1099
Swertz, M. A. et al. The MOLGENIS toolkit: rapid prototyping of biosoftware at the push of a button. BMC Bioinf. 11, S12 (2010).
doi: 10.1186/1471-2105-11-S12-S12
Dixon, P. VEGAN, a package of R functions for community ecology. J. Veg. Sci. 14, 927–930 (2003).
doi: 10.1111/j.1654-1103.2003.tb02228.x
Hsieh, T. C., Ma, K. H. & Chao, A. iNEXT: an R package for rarefaction and extrapolation of species diversity (Hill numbers). Methods Ecol. Evol. 7, 1451–1456 (2016).
doi: 10.1111/2041-210X.12613
Kaminski, J. et al. High-specificity targeted functional profiling in microbial communities with ShortBRED. PLoS Comput. Biol. 11, e1004557 (2015).
pubmed: 26682918 pmcid: 4684307 doi: 10.1371/journal.pcbi.1004557
Chen, L. et al. VFDB: a reference database for bacterial virulence factors. Nucleic Acids Res. 33, D325–D328 (2005).
pubmed: 15608208 doi: 10.1093/nar/gki008
Jia, B. et al. CARD 2017: expansion and model-centric curation of the comprehensive antibiotic resistance database. Nucleic Acids Res. 45, D566–D573 (2017).
pubmed: 27789705 doi: 10.1093/nar/gkw1004
Ziyatdinov, A. et al. lme4qtl: linear mixed models with flexible covariance structure for genetic studies of related individuals. BMC Bioinf. 19, 68 (2018).
doi: 10.1186/s12859-018-2057-x
Aitchison, J. The Statistical Analysis of Compositional Data. J. R. Stat. Soc. Series B Stat. Methodol. 44, 139–177 (1982).
Turnbaugh, P. J. et al. The Human Microbiome Project. Nature 449, 804–810 (2007).
pubmed: 17943116 pmcid: 3709439 doi: 10.1038/nature06244
Qin, J. et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464, 59–65 (2010).
pubmed: 20203603 pmcid: 3779803 doi: 10.1038/nature08821
Goodrich, J. K. et al. Human genetics shape the gut microbiome. Cell 159, 789–799 (2014).
pubmed: 25417156 pmcid: 4255478 doi: 10.1016/j.cell.2014.09.053
Friedman, J. & Alm, E. J. Inferring correlation networks from genomic survey data. PLoS Comput. Biol. 8, e1002687 (2012).
pubmed: 23028285 pmcid: 3447976 doi: 10.1371/journal.pcbi.1002687
Chen, L. et al. Gut microbial co-abundance networks show specificity in inflammatory bowel disease and obesity. Nat. Commun. 11, 4018 (2020).
pubmed: 32782301 pmcid: 7419557 doi: 10.1038/s41467-020-17840-y
Arumugam, M. et al. Enterotypes of the human gut microbiome. Nature 473, 174–180 (2011).
pubmed: 21508958 pmcid: 3728647 doi: 10.1038/nature09944

Auteurs

R Gacesa (R)

University of Groningen and University Medical Center Groningen, Department of Gastroenterology and Hepatology, Groningen, The Netherlands.
University of Groningen and University Medical Center Groningen, Department of Genetics, Groningen, The Netherlands.

A Kurilshikov (A)

University of Groningen and University Medical Center Groningen, Department of Genetics, Groningen, The Netherlands.

A Vich Vila (A)

University of Groningen and University Medical Center Groningen, Department of Gastroenterology and Hepatology, Groningen, The Netherlands.
University of Groningen and University Medical Center Groningen, Department of Genetics, Groningen, The Netherlands.

T Sinha (T)

University of Groningen and University Medical Center Groningen, Department of Genetics, Groningen, The Netherlands.

M A Y Klaassen (MAY)

University of Groningen and University Medical Center Groningen, Department of Gastroenterology and Hepatology, Groningen, The Netherlands.
University of Groningen and University Medical Center Groningen, Department of Genetics, Groningen, The Netherlands.

L A Bolte (LA)

University of Groningen and University Medical Center Groningen, Department of Gastroenterology and Hepatology, Groningen, The Netherlands.
University of Groningen and University Medical Center Groningen, Department of Genetics, Groningen, The Netherlands.

S Andreu-Sánchez (S)

University of Groningen and University Medical Center Groningen, Department of Genetics, Groningen, The Netherlands.
Department of Pediatrics, University of Groningen and University Medical Center Groningen, Groningen, The Netherlands.

L Chen (L)

University of Groningen and University Medical Center Groningen, Department of Genetics, Groningen, The Netherlands.
Department of Pediatrics, University of Groningen and University Medical Center Groningen, Groningen, The Netherlands.

V Collij (V)

University of Groningen and University Medical Center Groningen, Department of Gastroenterology and Hepatology, Groningen, The Netherlands.
University of Groningen and University Medical Center Groningen, Department of Genetics, Groningen, The Netherlands.

S Hu (S)

University of Groningen and University Medical Center Groningen, Department of Gastroenterology and Hepatology, Groningen, The Netherlands.
University of Groningen and University Medical Center Groningen, Department of Genetics, Groningen, The Netherlands.

J A M Dekens (JAM)

University of Groningen and University Medical Center Groningen, Department of Genetics, Groningen, The Netherlands.
Center of Development and Innovation, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

V C Lenters (VC)

University Medical Centre Utrecht, Julius Center for Health Sciences and Primary Care, Utrecht, The Netherlands.

J R Björk (JR)

University of Groningen and University Medical Center Groningen, Department of Gastroenterology and Hepatology, Groningen, The Netherlands.
University of Groningen and University Medical Center Groningen, Department of Genetics, Groningen, The Netherlands.

J C Swarte (JC)

University of Groningen and University Medical Center Groningen, Department of Gastroenterology and Hepatology, Groningen, The Netherlands.
University of Groningen and University Medical Center Groningen, Department of Genetics, Groningen, The Netherlands.

M A Swertz (MA)

University of Groningen and University Medical Center Groningen, Department of Genetics, Groningen, The Netherlands.
University of Groningen and University Medical Center Groningen, Genomics Coordination Center, Groningen, The Netherlands.

B H Jansen (BH)

University of Groningen and University Medical Center Groningen, Department of Gastroenterology and Hepatology, Groningen, The Netherlands.
University of Groningen and University Medical Center Groningen, Department of Genetics, Groningen, The Netherlands.

J Gelderloos-Arends (J)

University of Groningen and University Medical Center Groningen, Department of Genetics, Groningen, The Netherlands.

S Jankipersadsing (S)

University of Groningen and University Medical Center Groningen, Department of Genetics, Groningen, The Netherlands.

M Hofker (M)

Department of Pediatrics, University of Groningen and University Medical Center Groningen, Groningen, The Netherlands.

R C H Vermeulen (RCH)

University Medical Centre Utrecht, Julius Center for Health Sciences and Primary Care, Utrecht, The Netherlands.
Utrecht University, Institute for Risk Assessment Sciences (IRAS), Department of Population Health Sciences, Utrecht, The Netherlands.

S Sanna (S)

University of Groningen and University Medical Center Groningen, Department of Genetics, Groningen, The Netherlands.
Institute for Genetic and Biomedical Research (IRGB), National Research Council (CNR), Cagliari, Italy.

H J M Harmsen (HJM)

Department of Medical Microbiology and Infection prevention, University of Groningen and University Medical Center Groningen, Groningen, The Netherlands.

C Wijmenga (C)

University of Groningen and University Medical Center Groningen, Department of Genetics, Groningen, The Netherlands.

J Fu (J)

University of Groningen and University Medical Center Groningen, Department of Genetics, Groningen, The Netherlands. j.fu@umcg.nl.
Department of Pediatrics, University of Groningen and University Medical Center Groningen, Groningen, The Netherlands. j.fu@umcg.nl.

A Zhernakova (A)

University of Groningen and University Medical Center Groningen, Department of Genetics, Groningen, The Netherlands. sasha.zhernakova@gmail.com.

R K Weersma (RK)

University of Groningen and University Medical Center Groningen, Department of Gastroenterology and Hepatology, Groningen, The Netherlands. r.k.weersma@umcg.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH